Companies based in Bangalore

Video Interview Software Market 2018 Report Focuses on Market Dynamics and Opportunities, Development Status and Outlook, Analysis by Regions: Radiant Insights, Inc.

Retrieved on:

Monday, August 27, 2018

The factors that propel the growth of the Video Interview Software Market include time-saving, screening candidates from remote location, being cost-effective, less pressure on candidates.

Key Points:

The factors that propel the growth of the Video Interview Software Market include time-saving, screening candidates from remote location, being cost-effective, less pressure on candidates.
Video Interview Software Market is categorized based on applications as Large Enterprises, and Small and Medium Enterprises (SMEs).
Access 98 page research report with TOC on "Video Interview Software Market" available with Radiant Insights, Inc. @ https://www.radiantinsights.com/research/global-video-interview-software...
The key players contributing to the robust growth of the Video Interview Software Market comprise Montage, EasyHire, Talview, mroads, FaceCruit, Hiya, Recrumatic, Kira Talent, GreenJobInterview, RecRight.
This report studies the global Video Interview Software market, analyzes and researches the Video Interview Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Ensono Officially Closes $405M Acquisition of Wipro's Hosted Data Center Services Business

Retrieved on:

Thursday, June 28, 2018

Outsourcing, Business, Economy of India, BSE SENSEX, CNX Nifty, Companies based in Bangalore, Wipro, Peer-to-peer computing, Cloud computing, Client

DOWNERS GROVE, Ill., June 28, 2018 /PRNewswire/ -- Ensono , a leading hybrid IT services provider, closed on its acquisition of Wipro Limited's Hosted Data Center Services (DCS) business in U.S., Europe and Singapore.

Key Points:

DOWNERS GROVE, Ill., June 28, 2018 /PRNewswire/ -- Ensono , a leading hybrid IT services provider, closed on its acquisition of Wipro Limited's Hosted Data Center Services (DCS) business in U.S., Europe and Singapore.
Ensono and its clients will greatly benefit from the more than 900 associates joining the Ensono family.
By adding Wipro's Hosted Data Center business, Ensono has nearly doubled in size, expanded its client portfolio, and increased its annual revenue to more than $550 million.
For business leaders managing lots of complexity or disrupting the status quo, Ensono delivers complete Hybrid IT services, from mainframe to cloud, tailored to each client's journey.

InMobi Forms Strategic Partnership with Microsoft to Power New Cloud-Based Enterprise Platforms for Marketers

Retrieved on:

Tuesday, June 26, 2018

Computing, Cloud computing, Cloud infrastructure, IT infrastructure, Companies based in Bangalore, InMobi, Cloud storage, Microsoft Azure, Microsoft

SAN FRANCISCO and REDMOND, Wash., June 26, 2018 /PRNewswire/ -- InMobi , a global provider of enterprise platforms for marketers, today announced a strategic partnership with Microsoft Corp. to enable new-age CMOs in their transformational journey from digital to mobile marketing.

Key Points:

SAN FRANCISCO and REDMOND, Wash., June 26, 2018 /PRNewswire/ -- InMobi , a global provider of enterprise platforms for marketers, today announced a strategic partnership with Microsoft Corp. to enable new-age CMOs in their transformational journey from digital to mobile marketing.
Simultaneously, InMobi is significantly expanding its platform for marketers via the InMobi Marketing Cloud, adding to its decade-long market leadership through InMobi's Advertising Cloud.
"The combination of Microsoft Azure with InMobi's marketing platforms will deliver new intelligent customer experiences and business insights to organizations around the world."
With this partnership, InMobi will move in a phased manner to Microsoft Azure as its preferred cloud provider and tap into the power of its intelligent capabilities.

InMobi Forms Strategic Partnership with Microsoft to Power New Cloud-Based Enterprise Platforms for Marketers

Retrieved on:

Tuesday, June 26, 2018

Computing, Cloud computing, Cloud infrastructure, IT infrastructure, Companies based in Bangalore, InMobi, Cloud storage, Microsoft Azure, Microsoft

SAN FRANCISCO and REDMOND, Washington, June 26, 2018 /PRNewswire/ -- InMobi , a global provider of enterprise platforms for marketers, today announced a strategic partnership with Microsoft Corp. to enable new-age CMOs in their transformational journey from digital to mobile marketing.

Key Points:

SAN FRANCISCO and REDMOND, Washington, June 26, 2018 /PRNewswire/ -- InMobi , a global provider of enterprise platforms for marketers, today announced a strategic partnership with Microsoft Corp. to enable new-age CMOs in their transformational journey from digital to mobile marketing.
Simultaneously, InMobi is significantly expanding its platform for marketers via the InMobi Marketing Cloud, adding to its decade-long market leadership through InMobi's Advertising Cloud.
"The combination of Microsoft Azure with InMobi's marketing platforms will deliver new intelligent customer experiences and business insights to organizations around the world."
With this partnership, InMobi will move in a phased manner to Microsoft Azure as its preferred cloud provider and tap into the power of its intelligent capabilities.

U.S. FDA Approves Mylan and Biocon's Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®

Retrieved on:

Monday, June 4, 2018

Biotechnology, Medicine, Biology, Recombinant proteins, RTT, Biocon, Companies based in Bangalore, Biosimilar, Pegfilgrastim, Mylan, Food and Drug Administration, Insulin

Fulphila is the first FDA-approved biosimilar to Neulasta and the second biosimilar from Mylan and Biocon's joint portfolio approved in the U.S. Mylan anticipates launching Fulphila in the coming weeks, representing the first alternative, more affordable treatment option to Neulasta for oncology patients.

Key Points:

Fulphila is the first FDA-approved biosimilar to Neulasta and the second biosimilar from Mylan and Biocon's joint portfolio approved in the U.S. Mylan anticipates launching Fulphila in the coming weeks, representing the first alternative, more affordable treatment option to Neulasta for oncology patients.
Mylan President Rajiv Malik added: "Today's approval of Fulphila represents a meaningful step forward in the affordability and accessibility of cancer care in the U.S.
The data demonstrated that there were no clinically meaningful differences between the biosimilar product and Neulasta in terms of safety, purity and potency.
Our biosimilar to Neulasta is one of 11 biologic and insulin products co-developed by Mylan and Biocon for the global marketplace.